Effect of Food on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2018
Price : $35 *
At a glance
- Drugs Evacetrapib (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias
- Focus Pharmacokinetics
- 26 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Mar 2013 New trial record